Concord Biotech Announcements
Concord Biotech Limited has informed the Exchange regarding Resignation of Mr Lalit Sethi as Chief Financial Officer of the company w.e.f. January 05, 2026
08 Dec, 2025 | 02:24pm • Source: NSE
Early Retirement of Chief Financial officer (KMP) w.e.f. closing of working business hours on January 05,2026
08 Dec, 2025 | 01:53pm • Source: BSE
Early retirement of Chief Financial Officer
08 Dec, 2025 | 01:51pm • Source: BSE
Transcript of Q2FY26 earning call held on November'' 14, 2025
19 Nov, 2025 | 10:19am • Source: BSE
Newspaper clippings of Q2 FY25-26
14 Nov, 2025 | 04:10pm • Source: BSE
Intimation of Successful Completion of NAFDAC Inspection at our Oral Solid Dosage Unit-2, facility located at Valthera
08 Oct, 2025 | 11:04am • Source: BSE
Enclosed herewith the certificate under Regulation 74(5) of the SEBI(DP) regulations, 2018 for the quarter ended 30.09.2025
06 Oct, 2025 | 05:16pm • Source: BSE
Concord Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
25 Sep, 2025 | 10:07am • Source: NSE
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 19th September, 2025 at 11:00...
11 Sep, 2025 | 03:18pm • Source: BSE
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 17th September, 2025 at 10:00...
11 Sep, 2025 | 03:14pm • Source: BSE
Concord Biotech Limited has informed the Exchange about Schedule of meet
11 Sep, 2025 | 03:13pm • Source: NSE
Concord Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 09, 2025
11 Sep, 2025 | 03:08pm • Source: NSE
Pursuant to provision 44(3) of SEBI LODR, 2015 Please find enclosed herewith details of Voting result of 40thAGM and Scrutinizer''s Report on E-voting.
11 Sep, 2025 | 02:49pm • Source: BSE
Regulation 30 of the SEBI (LODR) Regulation, 2015, we hereby enclose the summary of the proceedings of AGM held on Tuesday, 9 September, 2025 through...
09 Sep, 2025 | 05:53pm • Source: BSE
Concord Biotech Limited has informed the Exchange about General Updates- Successful Completion Of EU GMP Inspection
21 Aug, 2025 | 02:50pm • Source: NSE
Intimation of successful completion of European Union Good Manufacturing Practices (EU GMP) inspection at our API facility in Limbassi
21 Aug, 2025 | 02:12pm • Source: BSE
Transcript of Q1FY26 Earning call held on August 11, 2025
18 Aug, 2025 | 06:14pm • Source: BSE
Enclosed herewith BRSR for FY 2024-2025
13 Aug, 2025 | 02:41pm • Source: BSE
Concord Biotech Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 09, 2025
13 Aug, 2025 | 11:53am • Source: NSE